Farmson has expanded beyond Paracetamol to become a world-class manufacturer of Caffeine API with a dedicated, state-of-the-art synthetic caffeine facility. Built on decades of chemical expertise, the plant follows a seven-stage process with strict impurity control and GMP compliance. Producing high-purity, stable Form-II caffeine that meets global pharmacopeial standards, Farmson ensures scalable supply, regulatory readiness, and consistent quality for pharmaceutical, food, and beverage applications worldwide.
For More Information Visit: https://www.farmson.com/blogs/caffeine-api-manufacturing-farmsons-state-of-the-art-facility/Farmson was established in the year 1971 for manufacturing of Paracetamol through phenol route. In the year 2000, we switched over to the PNCB route to manufacture Paracetamol. Currently, we are the GLOBAL LEADER in API Paracetamol production.
Subscribe to:
Post Comments (Atom)
Research & Development - Driving Innovation at Farmson
Research & Development is the engine behind Farmson’s long-term success in pharmaceutical manufacturing. With a dedicated, state-of-the-...
-
Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology...
-
Farmson has expanded beyond Paracetamol to become a world-class manufacturer of Caffeine API with a dedicated, state-of-the-art synthetic ca...
-
Farmson Basic Drugs, a leader in API manufacturing, expands its innovation with a world-class synthetic caffeine facility designed for pharm...

No comments:
Post a Comment